These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34969875)

  • 21. Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.
    Soto JA; Melo-González F; Riedel CA; Bueno SM; Kalergis AM
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus.
    Nanes BA; Zhu JL; Chong BF
    Lupus Sci Med; 2020; 7(1):e000364. PubMed ID: 32095249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of smoking in cutaneous lupus erythematosus.
    Piette EW; Foering KP; Chang AY; Okawa J; Ten Have TR; Feng R; Werth VP
    Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.
    Ker KJ; Teske NM; Feng R; Chong BF; Werth VP
    J Am Acad Dermatol; 2018 Dec; 79(6):1053-1060.e3. PubMed ID: 29969701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.
    Chang YC; Werth VP
    Curr Dermatol Rep; 2013 Mar; 2(1):48-57. PubMed ID: 33585073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus.
    Wieczorek IT; Propert KJ; Okawa J; Werth VP
    JAMA Dermatol; 2014 Mar; 150(3):291-6. PubMed ID: 24477339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
    Lim D; Kleitsch J; Werth VP
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus.
    Chakka S; Krain RL; Ahmed S; Concha JSS; Feng R; Merrill JT; Werth VP
    J Am Acad Dermatol; 2021 Jun; 84(6):1562-1567. PubMed ID: 32682879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review.
    Chakka S; Krain RL; Concha JSS; Chong BF; Merola JF; Werth VP
    Ann Transl Med; 2021 Mar; 9(5):431. PubMed ID: 33842652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE).
    Kuhn A; Kuehn E; Meuth AM; Haust M; Nyberg F; Werth V; Ruzicka T; Schmitt V; Bonsmann G;
    Autoimmun Rev; 2009 Jul; 8(8):702-12. PubMed ID: 19232553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The classification and diagnosis of cutaneous lupus erythematosus.
    Kuhn A; Landmann A
    J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus.
    Cho SK; Vazquez T; Werth VP
    Expert Opin Investig Drugs; 2023 May; 32(5):345-353. PubMed ID: 37148249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).
    Biazar C; Sigges J; Patsinakidis N; Ruland V; Amler S; Bonsmann G; Kuhn A;
    Autoimmun Rev; 2013 Jan; 12(3):444-54. PubMed ID: 23000206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OMERACT systemic lupus erythematosus domain survey.
    Nielsen W; Strand V; Simon L; Pinsker E; Bonilla D; Morand E; Thumboo J; Aringer M; Mosca M; Bruce I; Parodis I; Kim A; Desai M; Enman Y; Shea B; Wallace DJ; Chaichian Y; Navarra S; Aranow C; Mackay M; Trotter K; Tayer-Shifman OE; Duarte-García A; Shan Tam L; Ugarte-Gil MF; Pons-Estel GJ; Reynolds JA; Nikpour M; Hoi A; Romero-Diaz J; Aggarwal A; Mok CC; Fujio K; Ramsey-Goldman R; Gladman DD; Arnaud L; Bultink IEM; Ruiz-Irastorza G; Inês LS; Appenzeller S; Dobrowolski C; Clarke AE; Kamen DL; Barraclough M; Tani C; Gómez-Puerta JA; Werth VP; Katz P; Nowrouzi-Kia B; Johnson SR; Drucker AM; Touma Z;
    Semin Arthritis Rheum; 2024 Oct; 68():152520. PubMed ID: 39106780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.
    Albrecht J; Taylor L; Berlin JA; Dulay S; Ang G; Fakharzadeh S; Kantor J; Kim E; Militello G; McGinnis K; Richardson S; Treat J; Vittorio C; Van Voorhees A; Werth VP
    J Invest Dermatol; 2005 Nov; 125(5):889-94. PubMed ID: 16297185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review.
    Chasset F; Francès C
    Drugs; 2019 Jul; 79(11):1199-1215. PubMed ID: 31228033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.
    Bein D; Kuehn E; Meuth AM; Amler S; Haust M; Nyberg F; Sauerland C; Luger TA; Bonsmann G; Kuhn A
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):652-9. PubMed ID: 20849444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.
    Tarazi M; Gaffney RG; Pearson D; Kushner CJ; Werth VP
    Br J Dermatol; 2019 Jun; 180(6):1468-1472. PubMed ID: 30269332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.